About Medilloyd Medicament Private Limited
Data last updated:
Medilloyd Medicament Private Limited is a private limited company based in Cuttack, Odisha, India. The company is currently undergoing Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency professional. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 April 2012.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U24230OR2012PTC015269. Its GSTIN is 21AAICM1318C1Z7 (Odisha). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors Shiba Prasanna Jena (Managing Director) and Subhalaxmi Jena.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Side Lane Of Sbi Hyderabad Kanika Chhak Tulsipur, Cuttack, Odisha, India – 753008.
As per the financials filed for FY 2020, the company reported a revenue of ₹9.88 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹6.57 Lakh (net margin 0.7%) and EBITDA of ₹53.67 Lakh (EBITDA margin 5.4%). Revenue has declined at a compounded annual rate (CAGR) of 8% over three years and 2% over five years.
As per MCA filings, the company has open charges of ₹6.85 Cr and satisfied charges of ₹2.7 Cr on record. Court records list 23 cases involving the company, including 4 filed by the company and 19 filed against it; 9 cases are pending.
The last known website on record is medilloydmedicament.com.
Company details
Contact details
Medilloyd Medicament Private Limited's registered office is in Cuttack, Odisha. Its website is medilloydmedicament.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressSide Lane Of Sbi Hyderabad Kanika Chhak Tulsipur, Cuttack, Odisha, India – 753008
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Medilloyd Medicament Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medilloyd Medicament is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medilloyd Medicament Private Limited, buy the company report.
Financials of Medilloyd Medicament Private Limited
FY 2020 filings availableMedilloyd Medicament Private Limited reported revenue of ₹9.88 Cr (up 11% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue rose 11% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹9.88 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹53.67 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.57 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.4% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medilloyd Medicament Private Limited, buy the company report.
Board of directors of Medilloyd Medicament Private Limited
Medilloyd Medicament has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Subhalaxmi Jena Also directs: Oppurtune Ventures Private Limited | Director | 20 Apr 2012 | 14 Years 6 Months | As last reported |
| Shiba Prasanna Jena Also directs: Oppurtune Ventures Private Limited | Managing Director | 20 Apr 2012 | 14 Years 6 Months | As last reported |
Peer comparison
Medilloyd Medicament Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ventus Pharmaceuticals Private Limited | ₹9.89 Cr (FY 2025) | 12.0% | Panchkula, Haryana, India | |||
| Erweka (India) Private Limited | ₹9.88 Cr (FY 2025) | 43.0% | Ahmedabad, Gujarat, India | |||
| Medilloyd Medicament Private Limitedthis company | ₹9.88 Cr (FY 2020) | ₹6.57 Lakh | 0.7% | 11.0% | Cuttack, Odisha, India | |
| Brio Bliss Life Science Private Limited | ₹9.84 Cr (FY 2021) | -35.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Medilloyd Medicament Private Limited, buy the company report.
Auditor
Medilloyd Medicament Private Limited is audited by H K CHANDAK & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| H K CHANDAK & CO | FY 2020 | 317153E |
Shareholding
The shareholding of Medilloyd Medicament Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Medilloyd Medicament Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Mar 2017 | 100093459 | Others | ₹4.1 Cr | Open | |
| 24 Sep 2015 | 10608189 | Dcb Bank Limited | ₹2.75 Cr | Open | |
| 24 Feb 2014 | 10487845 | Canara Bank | ₹2.7 Cr | Satisfied |
To see the full charge records of Medilloyd Medicament Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Medilloyd Medicament Private Limited has 23 court cases on record: 4 filed by Medilloyd Medicament, 19 filed against it. 9 cases are pending and 14 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 20 | 17 | 8 |
| High courts | 2 | 2 | 0 |
| NCLT | 1 | 0 | 1 |
Cases on record (5 of 23)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Khurda, Odisha | Court case (I . c. c) | Filed against the company by HDFC Bank | Pending |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Tata Capital Financial Services Ltd. | Pending |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Kotak Mahindra Bank Ltd. | Pending |
| High Court of Orissa | Writ petition | Filed against the company by DCB Bank Limited, Mumbai | Disposed |
| High Court, ORISSA | Writ petition | Filed against the company by DCB Bank Ltd.,Mumbai | Disposed |
To see the full case history of Medilloyd Medicament Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medilloyd Medicament Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medilloyd Medicament has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AAICM1318C1Z7 | Odisha | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medilloyd Medicament Private Limited, buy the company report.
Recent activity
Medilloyd Medicament Private Limited has 3 board changes on record since 2012: 2 appointments and 1 cessation. The latest: Jayant Kumar Patnaik ceased to be Director on 01 Aug 2013.
Frequently asked questions
Medilloyd Medicament is undergoing "Corporate Insolvency Resolution Process" (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency resolution professional. The company may not be able to independently enter into new commitments during this period. This is a high-risk status - verify the resolution status before any engagement.
Medilloyd Medicament is a company under insolvency, formerly operating as a private limited company based in Cuttack, Odisha, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 April 2012 and is registered under CIN U24230OR2012PTC015269. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Medilloyd Medicament has 2 current directors:
- Shiba Prasanna Jena - Managing Director
- Subhalaxmi Jena - Director
The latest financial statements of Medilloyd Medicament on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Medilloyd Medicament is U24230OR2012PTC015269. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medilloyd Medicament has open charges of ₹6.85 Cr and satisfied charges of ₹2.7 Cr as per latest MCA filings.
Medilloyd Medicament has 23 court cases on record: 4 filed by the company and 19 filed against it. 9 are pending. Most are in the district courts.
Medilloyd Medicament was incorporated on 20 April 2012. It is registered with the Registrar of Companies, Cuttack.
The peers of Medilloyd Medicament by revenue are Ventus Pharmaceuticals Private Limited, Erweka (India) Private Limited, Brio Bliss Life Science Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Jayant Kumar Patnaik ceased to be Director on 01 Aug 2013. Shiba Prasanna Jena was appointed as Managing Director on 20 Apr 2012. Subhalaxmi Jena was appointed as Director on 20 Apr 2012.
Medilloyd Medicament can be reached through the website medilloydmedicament.com. Its registered office is in Cuttack, Odisha, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
